Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).
Saved in:
| Title: | Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial). |
|---|---|
| Authors: | Ambrosioni J; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jambrosioni@intramed.net., de Lazzari E; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Sánchez-Palomino S; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Bailón L; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Suanzes P; Infectious Diseases Department, Hospital Universitario Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain., Busca C; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; HIV Unit, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain., Ramos-Ruperto L; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; HIV Unit, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain., Orviz E; Centro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Rivero Á; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; BCN Checkpoint, Barcelona, Spain., Mothe B; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; IrsiCaixa, Badalona, Spain; Department of Infectious Diseases and Immunity, University of Vic - Central University of Catalonia (UVic-UCC), Barcelona, Spain., Romero JD; Centro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Falcó V; Infectious Diseases Department, Hospital Universitario Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain., Vicens-Artés S; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain., Moraga E; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain., Cruceta A; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain., Mallolas J; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Miró JM; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Reial Academia de Medicina de Catalunya (RAMC), Barcelona, Spain. Electronic address: jmmiro@ub.edu. |
| Corporate Authors: | BIC-PHI Study Group |
| Source: | The Journal of infection [J Infect] 2025 Nov; Vol. 91 (5), pp. 106651. Date of Electronic Publication: 2025 Nov 07. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41207637 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ambrosioni+J%22">Ambrosioni J</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jambrosioni@intramed.net.<br /><searchLink fieldCode="AU" term="%22de+Lazzari+E%22">de Lazzari E</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Palomino+S%22">Sánchez-Palomino S</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bailón+L%22">Bailón L</searchLink>; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Suanzes+P%22">Suanzes P</searchLink>; Infectious Diseases Department, Hospital Universitario Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Busca+C%22">Busca C</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; HIV Unit, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramos-Ruperto+L%22">Ramos-Ruperto L</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; HIV Unit, Hospital Universitario La Paz-Carlos III, IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Orviz+E%22">Orviz E</searchLink>; Centro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rivero+Á%22">Rivero Á</searchLink>; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; BCN Checkpoint, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mothe+B%22">Mothe B</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; IrsiCaixa, Badalona, Spain; Department of Infectious Diseases and Immunity, University of Vic - Central University of Catalonia (UVic-UCC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Romero+JD%22">Romero JD</searchLink>; Centro Sanitario Sandoval, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Falcó+V%22">Falcó V</searchLink>; Infectious Diseases Department, Hospital Universitario Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vicens-Artés+S%22">Vicens-Artés S</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moraga+E%22">Moraga E</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cruceta+A%22">Cruceta A</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mallolas+J%22">Mallolas J</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Miró+JM%22">Miró JM</searchLink>; HIV Unit, Hospital Clínic de Barcelona (HCB) - Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Reial Academia de Medicina de Catalunya (RAMC), Barcelona, Spain. Electronic address: jmmiro@ub.edu. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22BIC-PHI+Study+Group%22">BIC-PHI Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227908424%22">The Journal of infection</searchLink> [J Infect] 2025 Nov; Vol. 91 (5), pp. 106651. <i>Date of Electronic Publication: </i>2025 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7908424 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-2742 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201634453%22">01634453 </searchLink><i>NLM ISO Abbreviation: </i>J Infect <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41207637 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jinf.2025.106651 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 106651 Titles: – TitleFull: Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ambrosioni J – PersonEntity: Name: NameFull: de Lazzari E – PersonEntity: Name: NameFull: Sánchez-Palomino S – PersonEntity: Name: NameFull: Bailón L – PersonEntity: Name: NameFull: Suanzes P – PersonEntity: Name: NameFull: Busca C – PersonEntity: Name: NameFull: Ramos-Ruperto L – PersonEntity: Name: NameFull: Orviz E – PersonEntity: Name: NameFull: Rivero Á – PersonEntity: Name: NameFull: Mothe B – PersonEntity: Name: NameFull: Romero JD – PersonEntity: Name: NameFull: Falcó V – PersonEntity: Name: NameFull: Vicens-Artés S – PersonEntity: Name: NameFull: Moraga E – PersonEntity: Name: NameFull: Cruceta A – PersonEntity: Name: NameFull: Mallolas J – PersonEntity: Name: NameFull: Miró JM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-2742 Numbering: – Type: volume Value: 91 – Type: issue Value: 5 Titles: – TitleFull: The Journal of infection Type: main |
| ResultId | 1 |
